Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 4, 2021BMC Infectious DiseasesOpen Access

Impact of antiviral treatment on long-term prognosis in non-immunocompromised patients with CMV reactivation

View Full Paper
Ask AI
Bookmark
Share

Authors

GPGa Eun ParkHKHyun Kyun KiKonkuk University Medical CenterJKJae‐Hoon KoSamsung Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Park et al. (2021) studied this question.

synapsesocial.com/papers/6ab08dd465076800a6e78917https://doi.org/10.1186/s12879-021-06098-4
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cytomegalovirus reactivation and mortality in patients with acute respiratory distress syndrome2015 · 105 citations
  2. 2Performance Evaluation of the Real-Q Cytomegalovirus (CMV) Quantification Kit Using Two Real-Time PCR Systems for Quantifying CMV DNA in Whole Blood2016 · 9 citations
  3. 3Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study2012 · 308 citations
  4. 4Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients2002 · 1,244 citations
  5. 5Cytomegalovirus infection in non-immunosuppressed critically ill patients2011 · 62 citations